Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The DTRA has announced priorities and initial initiatives designed to realize the full potential of decentralized research to improve access and participation to make clinical trials more efficient, accessible, and equitable.
read more
The Decentralized Trials & Research Alliance (DTRA) today announced that it now counts more than 100 member organizations united in the shared mission to make clinical-trial participation widely accessible to patients.
read more
Tuesday, February 09, 2021
Catalent has signed an agreement to provide Decibel Therapeutics with process and analytical development, and CGMP clinical manufacturing services, for Decibel’s lead investigational gene therapy product candidate, DB-OTO.
read more
Wednesday, August 03, 2016
Definiens, a provider of Tissue Phenomics solutions for diagnostic development and commercialization, has announced the release of its Clinical Development Offering, making the company a provider of comprehensive tissue-based services from discovery ...
read more
DefiniGEN has identified iPSC-derived intestinal organoids that could be used to help structure in vitro studies of the biology of SARS-CoV2 infection across cohorts of multiple patients.
read more
Delavau Pharmaceutical Partners has welcomed industry veteran Curt Pagano to its team as the Vice President of Quality and Regulatory.
read more
DelMar Pharmaceuticals announced its financial results for the third quarter ended March 31, 2018.
read more
DelMar Pharmaceuticals announced an agreement with PRA Health Sciences to conduct the Phase 3 trial of VAL-083 in recurrent glioblastoma multiforme.
read more
DelMar Pharmaceuticals announced the closing of a $9 million offering of common stock and warrants which was led by leading healthcare dedicated institutional investors.
read more
DelMar Pharmaceuticals has announced the appointments of three additional neuro-oncologists to its Scientific Advisory Board (SAB).
read more
Wednesday, October 16, 2019
Delpharm and Famar have entered into exclusive negotiations for the acquisition by Delpharm of five Famar manufacturing sites in France, the Netherlands and Canada.
read more
Delpharm announced that it has reached an agreement with the Government of Canada to modernize its injectable manufacturing facility in Boucherville.
read more
Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical company and pioneer in the development of cellular immunotherapy, announced the appointment of Sherry Saurini as Vice President of Quality, effective August 23, 2021. Saurini will focus ...
read more
Wednesday, November 17, 2021
Flagship Facility Services has announced the finalization of a partnership with DENS Facility Services (DENS), headquartered in Greater Boston and a leader in providing Life Sciences laboratory support and facility maintenance services to that ...
read more
The contract provides partial funding for ongoing development of ARX-04, including Phase 3 clinical, manufacturing and regulatory activities.
read more